Vaginal Progesterone for Treatment of Threatened Miscarriage
Status:
Unknown status
Trial end date:
2018-02-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the efficacy of vaginal micronized progesterone in the
treatment of threatened miscarriage. All eligible pregnant women will be randomized to either
receive vaginal progesterone or no treatment.Evaluation will be two weeks after intervention,
then every 4 weeks up to 28 weeks gestation or termination of pregnancy.